Usana records strong results in China despite internal probe

In the midst of an internal review of its Chinese operations, Usana Health Sciences reported a 6.2% increase in sales derived almost entirely from the Asia Pacific region.

Related Topics

Markets & trendsOmega-3s & nutritional oilsProteins, peptides, amino acidsVitamins & minerals BotanicalsCardiovascular healthHealthy agingActive nutrition

Related news

China probe propels Usana stock price slide

By Hank Schultz

Usana Health Sciences’ shares declined as the company reported disappointing earnings and announced an internal investigation of its business in mainland China.

Traders pound USANA's stock over slowdown in China sales

By Hank Schultz

USANA Health Sciences reported $232.6 million in net sales in its fourth quarter, a 2.1% year-over-year increase. That amounted to $1.83 in earnings per share, but these figures disappointed analysts, and the company’s share price tumbled as a result.

Usana's center of gravity continues to shift toward China

By Hank Schultz

Usana Health Sciences posted strong fourth quarter results dampened somewhat by a discounting program undertaken to boost sales, the company announced this week. The company continued to show the fastest sales increases in China, while results in North...